ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹1,688 Cr | ₹1,554 Cr | ₹1,225 Cr | ₹1,111 Cr | ₹1,237 Cr |
What is the latest Total Liabilities ratio of ORCHID PHARMA ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹1,688 Cr |
| Mar2024 | ₹1,554 Cr |
| Mar2023 | ₹1,225 Cr |
| Mar2022 | ₹1,111 Cr |
| Mar2021 | ₹1,237 Cr |
How is Total Liabilities of ORCHID PHARMA Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,688 Cr | 8.62 | |
| Mar2024 | ₹1,554 Cr | 26.83 | |
| Mar2023 | ₹1,225 Cr | 10.32 | |
| Mar2022 | ₹1,111 Cr | -10.24 | |
| Mar2021 | ₹1,237 Cr | - | |
Compare Total Liabilities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹4,389.4 Cr | 0.9% | 18.9% | -38.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,034.0 Cr | 0.9% | 5.3% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,211.0 Cr | -2.3% | -3.3% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹124,875.0 Cr | -3.3% | 2.8% | 19.7% | Stock Analytics | |
| CIPLA | ₹122,082.0 Cr | -1.6% | -9.2% | 4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,873.0 Cr | NA | -3.5% | 4.6% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 0.9% |
18.9% |
-38.8% |
| SENSEX | 0.8% |
1% |
9.9% |
You may also like the below Video Courses